Budesonide + Formoterol (Neumoterol) is indicated in adults, and adolescents aged 12-17 years, for the regular treatment of asthma where use of a combination (inhaled corticosteroid and a long-acting beta2 adrenoceptor agonist) is appropriate: Patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short-acting beta2 adrenoceptor agonists, or Patients already adequately controlled with both inhaled corticosteroids and long-acting beta2-adrenoceplor agonists.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
